Literature DB >> 19929432

Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells.

Shanmugam Muruganandan1, Alexandra A Roman, Christopher J Sinal.   

Abstract

Maintenance of healthy bone mass requires a well-coordinated balance between the ongoing processes of bone formation and bone resorption. Bone-forming osteoblasts derive from resident adult stem cells within bone marrow called bone marrow stromal cells (BMSCs). These BMSCs are multipotent and also can give rise to adipocytes, which do not contribute directly to bone formation but may influence bone remodeling through the release of bioactive signaling molecules. Chemerin is a novel adipocyte-derived signaling molecule that promotes adipocyte differentiation. In this study we examined the role of chemerin and the cognate receptors CMKLR1 and CCRL2 as determinants of osteoblast and adipocyte differentiation of the preosteoblast 7F2 cell line and of primary BMSCs. Expression and secretion of chemerin increased dramatically with adipocyte differentiation of these cells. Functionally, knockdown of chemerin or CMKLR1 expression using RNA interference abrogated adipocyte differentiation, clonal expansion, and basal proliferation of BMSCs. In contrast, knockdown of either gene was associated with increased osteoblast marker gene expression and mineralization in response to osteoblastogenic stimuli. Forced expression of the adipogenic transcription factor peroxisome proliferator-activated receptor gamma (PPARgamma) induced chemerin expression and partially rescued the loss of adipogenesis associated with chemerin or CMKLR1 knockdown in BMSCs. Taken together, these data support a novel role for chemerin/CMKLR1 signaling in regulating adipogenesis and osteoblastogenesis of bone marrow-derived precursor cells. These data reveal a potential role for this signaling pathway as a modulator of bone mass. Copyright 2010 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19929432     DOI: 10.1359/jbmr.091106

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  56 in total

1.  Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.

Authors:  Lang Li; Tammy Sajdyk; Ellen M L Smith; Chien Wei Chang; Claire Li; Richard H Ho; Raymond Hutchinson; Elizabeth Wells; Jodi L Skiles; Naomi Winick; Paul L Martin; Jamie L Renbarger
Journal:  Clin Pharmacol Ther       Date:  2019-01-21       Impact factor: 6.875

2.  Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults.

Authors:  S K Malin; S D Navaneethan; A Mulya; H Huang; J P Kirwan
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

3.  Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Authors:  Xifeng Wu; Yuanqing Ye; Rafael Rosell; Christopher I Amos; David J Stewart; Michelle A T Hildebrandt; Jack A Roth; John D Minna; Jian Gu; Jie Lin; Shama C Buch; Tomoko Nukui; Jose Luis Ramirez Serrano; Miquel Taron; Adrian Cassidy; Charles Lu; Joe Y Chang; Scott M Lippman; Waun Ki Hong; Margaret R Spitz; Marjorie Romkes; Ping Yang
Journal:  J Natl Cancer Inst       Date:  2011-04-11       Impact factor: 13.506

4.  Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis.

Authors:  Shanmugam Muruganandan; Sebastian D Parlee; Jillian L Rourke; Matthew C Ernst; Kerry B Goralski; Christopher J Sinal
Journal:  J Biol Chem       Date:  2011-05-14       Impact factor: 5.157

Review 5.  Adipokines in bone disease.

Authors:  Elena Neumann; Susann Junker; Georg Schett; Klaus Frommer; Ulf Müller-Ladner
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

6.  Bone marrow sFRP5 level is negatively associated with bone formation markers.

Authors:  H Chen; Y He; D Wu; G Dai; C Zhao; W Huang; D Jiang
Journal:  Osteoporos Int       Date:  2016-12-17       Impact factor: 4.507

7.  Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance.

Authors:  Matthew C Ernst; Ian D Haidl; Luis A Zúñiga; Helen J Dranse; Jillian L Rourke; Brian A Zabel; Eugene C Butcher; Christopher J Sinal
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

8.  NOS1AP Functionally Associates with YAP To Regulate Hippo Signaling.

Authors:  Leanne Clattenburg; Michael Wigerius; Jiansong Qi; Jan K Rainey; Jillian L Rourke; Shanmugam Muruganandan; Christopher J Sinal; James P Fawcett
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

9.  Resolvin E1 and chemokine-like receptor 1 mediate bone preservation.

Authors:  Li Gao; Dan Faibish; Gabrielle Fredman; Bruno S Herrera; Nan Chiang; Charles N Serhan; Thomas E Van Dyke; Robert Gyurko
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

Review 10.  Chemerin: A comprehensive review elucidating the need for cardiovascular research.

Authors:  David J Ferland; Stephanie W Watts
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.